171 related articles for article (PubMed ID: 31565846)
1. Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington's disease.
Norrbacka S; Lindholm D; Myöhänen TT
J Cell Mol Med; 2019 Dec; 23(12):8511-8515. PubMed ID: 31565846
[No Abstract] [Full Text] [Related]
2. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.
Chen M; Wolynes PG
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517
[TBL] [Abstract][Full Text] [Related]
3. A Liquid to Solid Phase Transition Underlying Pathological Huntingtin Exon1 Aggregation.
Peskett TR; Rau F; O'Driscoll J; Patani R; Lowe AR; Saibil HR
Mol Cell; 2018 May; 70(4):588-601.e6. PubMed ID: 29754822
[TBL] [Abstract][Full Text] [Related]
4. Autophagy preferentially degrades non-fibrillar polyQ aggregates.
Zhao DY; Bäuerlein FJB; Saha I; Hartl FU; Baumeister W; Wilfling F
Mol Cell; 2024 May; 84(10):1980-1994.e8. PubMed ID: 38759629
[TBL] [Abstract][Full Text] [Related]
5. The 17-residue-long N terminus in huntingtin controls stepwise aggregation in solution and on membranes via different mechanisms.
Pandey NK; Isas JM; Rawat A; Lee RV; Langen J; Pandey P; Langen R
J Biol Chem; 2018 Feb; 293(7):2597-2605. PubMed ID: 29282287
[TBL] [Abstract][Full Text] [Related]
6. Polyglutamine tracts regulate beclin 1-dependent autophagy.
Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC
Nature; 2017 May; 545(7652):108-111. PubMed ID: 28445460
[TBL] [Abstract][Full Text] [Related]
7. Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease.
Wyttenbach A; Carmichael J; Swartz J; Furlong RA; Narain Y; Rankin J; Rubinsztein DC
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2898-903. PubMed ID: 10717003
[TBL] [Abstract][Full Text] [Related]
8. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.
Aladdin A; Király R; Boto P; Regdon Z; Tar K
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806
[TBL] [Abstract][Full Text] [Related]
9. Calmidazolium Chloride and Its Complex with Serum Albumin Prevent Huntingtin Exon1 Aggregation.
Singh V; Deepak RNVK; Sengupta B; Joshi AS; Fan H; Sen P; Thakur AK
Mol Pharm; 2018 Aug; 15(8):3356-3368. PubMed ID: 29979597
[TBL] [Abstract][Full Text] [Related]
10. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.
Banerjee M; Datta M; Bhattacharyya NP
Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155
[TBL] [Abstract][Full Text] [Related]
11. Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.
Luo H; Cao L; Liang X; Du A; Peng T; Li H
Mol Neurobiol; 2018 Oct; 55(10):7652-7668. PubMed ID: 29430620
[TBL] [Abstract][Full Text] [Related]
12. Visualization of prion-like transfer in Huntington's disease models.
Jansen AH; Batenburg KL; Pecho-Vrieseling E; Reits EA
Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):793-800. PubMed ID: 28040507
[TBL] [Abstract][Full Text] [Related]
13. Prolyl oligopeptidase inhibition attenuates the toxicity of a proteasomal inhibitor, lactacystin, in the alpha-synuclein overexpressing cell culture.
Myöhänen TT; Norrbacka S; Savolainen MH
Neurosci Lett; 2017 Jan; 636():83-89. PubMed ID: 27818354
[TBL] [Abstract][Full Text] [Related]
14. Proteostasis of Huntingtin in Health and Disease.
Koyuncu S; Fatima A; Gutierrez-Garcia R; Vilchez D
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753941
[TBL] [Abstract][Full Text] [Related]
15. Cryo-electron tomography provides topological insights into mutant huntingtin exon 1 and polyQ aggregates.
Galaz-Montoya JG; Shahmoradian SH; Shen K; Frydman J; Chiu W
Commun Biol; 2021 Jul; 4(1):849. PubMed ID: 34239038
[TBL] [Abstract][Full Text] [Related]
16. Protein aggregation and neurodegeneration: clues from a yeast model of Huntington's disease.
Bocharova N; Chave-Cox R; Sokolov S; Knorre D; Severin F
Biochemistry (Mosc); 2009 Feb; 74(2):231-4. PubMed ID: 19267681
[TBL] [Abstract][Full Text] [Related]
17. A toxic mutant huntingtin species is resistant to selective autophagy.
Fu Y; Wu P; Pan Y; Sun X; Yang H; Difiglia M; Lu B
Nat Chem Biol; 2017 Nov; 13(11):1152-1154. PubMed ID: 28869595
[TBL] [Abstract][Full Text] [Related]
18. Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease.
Martín-Aparicio E; Yamamoto A; Hernández F; Hen R; Avila J; Lucas JJ
J Neurosci; 2001 Nov; 21(22):8772-81. PubMed ID: 11698589
[TBL] [Abstract][Full Text] [Related]
19. Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington's disease.
Zeng Y; Guo W; Xu G; Wang Q; Feng L; Long S; Liang F; Huang Y; Lu X; Li S; Zhou J; Burgunder JM; Pang J; Pei Z
Drug Des Devel Ther; 2016; 10():1443-51. PubMed ID: 27110099
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin ligase UBR5 suppresses proteostasis collapse in pluripotent stem cells from Huntington's disease patients.
Koyuncu S; Saez I; Lee HJ; Gutierrez-Garcia R; Pokrzywa W; Fatima A; Hoppe T; Vilchez D
Nat Commun; 2018 Jul; 9(1):2886. PubMed ID: 30038412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
